| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/09/2005 | CN1192038C Monoclonal antibodies against HIV-1 and vaccines made thereof |
| 03/08/2005 | US6864229 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 03/03/2005 | US20050048639 Caspase-8 binding protein, its preparation and use |
| 03/03/2005 | US20050048632 Novel DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof |
| 03/03/2005 | US20050048629 theTat peptide is self cell-penetrating, is of HIV Type-1 and is bound to N-terminal amino acid residue of human parathyroid hormone-derived peptide; high stability and superior skin absorption; superior lipolysis effects and improved durability |
| 03/03/2005 | US20050048586 Using taste transduction G-protein coupled receptor polypeptides as diagnostic tools which identify modulators which enhance flavors and taste |
| 03/03/2005 | US20050048520 Nogo receptor homologs |
| 03/03/2005 | US20050048479 Adenylyl and guanylyl cyclases |
| 03/03/2005 | US20050048476 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents |
| 03/03/2005 | US20050048471 Albumin derivatives with therapeutic functions |
| 03/03/2005 | US20050048068 Major histocompatibility complex epitopes; immunotherapy ; induce immunology response |
| 03/03/2005 | US20050048066 Identification of potential immunodominant acetylcholine receptor alpha subunit |
| 03/03/2005 | US20050048064 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 03/03/2005 | US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections |
| 03/02/2005 | EP1509541A2 Novel recombinant anticoagulant proteins |
| 03/02/2005 | EP1509253A1 Chimeric cd154 |
| 03/02/2005 | EP1299327A4 Phosphorylated polypeptides and uses related thereto |
| 03/02/2005 | EP1141294B1 Method of enhancing the biological activity of ligands |
| 03/02/2005 | EP0741868B1 Immunoassays for prostate specific antigen |
| 03/02/2005 | CN1191362C Streptococcus antigens |
| 03/02/2005 | CN1191277C Fusion protein with specific affinity t liver cell and its nucleotide sequence |
| 03/02/2005 | CN1191273C Long lasting insulinotropic peptides |
| 03/02/2005 | CN1191271C Thymic peptide fusion protein as one new interferon and its prepn. |
| 03/02/2005 | CN1191090C Use of enterobaterium protein ompA associated with antigen for generating antiviral, aniparsitic or antitumoral cytotoxic response |
| 03/02/2005 | CN1191089C Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomal |
| 03/01/2005 | US6861243 Cloning gene; biocatalysts; forming cyanohydrins |
| 03/01/2005 | US6861054 suPAR stimulating activity of tcuPA-mediated fibrinolysis and different uses thereof |
| 03/01/2005 | CA2133326C Fusion proteins comprising tumor necrosis factor receptor |
| 02/24/2005 | WO2005017093A2 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | WO2004077062B1 Method for selecting a candidate drug compound |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050043198 A related nucleic acid, expression vector, host cell, and protein, the protein having a common epitope with the protease; the protease acts as an unspecific endopeptidase; cleaners also contain an amylase, cellulase, hemicellulase, oxidoreductase, or lipase; cosmetics |
| 02/24/2005 | US20050042729 Expression vector comprising nucleotide sequences conding immunoglobulin/interferon fusion for use in targeting and treatment of liver disorders |
| 02/24/2005 | US20050042680 Single chain antigen-binding polypeptides for polymer conjugation |
| 02/24/2005 | US20050042655 Using hematopoietoic regulatory related polypeptide (HEMA) for use in diagnosis, treatment and prevention of hematopoietic disorders |
| 02/24/2005 | US20050042199 Comprising interleukin-2 (IL-2) and tlp peptides ( Tumour Liberated Particles) protein complexes; antitumor and anticarcinogenic agents; immunotherapy |
| 02/24/2005 | CA2535863A1 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | CA2535670A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | CA2534629A1 Engineered proteases for affinity purification and processing of fusion proteins |
| 02/24/2005 | CA2529553A1 Ribonucleases and methods of making them recombinantly |
| 02/23/2005 | EP1507869A2 Improved receptor detection |
| 02/23/2005 | EP1507852A2 Nucleic acids and proteins with thioredoxin reductase activity |
| 02/23/2005 | CN1585778A Modified anti-TNF alpha antibody |
| 02/23/2005 | CN1583795A Human interferon analogue with long-lasting biological effects |
| 02/23/2005 | CN1583794A Targeted anti-tumour fused protein containing adenovirus E40rf4 protein |
| 02/23/2005 | CN1583787A Stimulated polypeptide, its coding genes and use of capsule protein HVR1 of hepatitis C virus |
| 02/23/2005 | CN1190447C Human hyaloid band B cell epitose fusogenic peptide and its production process |
| 02/22/2005 | US6858704 Oligopeptide sequences with c-terminal acidic tails (ATS); increased stability in enzymes, foods, medicines and chemical products |
| 02/22/2005 | US6858578 Chimeric proteins for use in transport of a selected substance into cells |
| 02/22/2005 | US6858210 For inducing tolerance in an individual; bind to anti-cardiolipin ( beta 2GPI-dependent antiphospholipid) |
| 02/22/2005 | US6858207 Methods and materials relating to novel CD39-like polypeptides |
| 02/22/2005 | CA2271232C Modified protein c and methods of use thereof |
| 02/22/2005 | CA2093022C Targeted immunostimulation with bispecific reagents |
| 02/17/2005 | WO2005014623A2 Compounds comprising lpa |
| 02/17/2005 | WO2005014621A1 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050037969 Molecular interactions in hematopoietic cells |
| 02/17/2005 | US20050037412 Thermostable Taq polymerase fragment |
| 02/17/2005 | US20050037355 Measuring intracellular adenosine triphosphate and/or gene expression in transgenic cell via monitoring luciferin bioluminescent signals; genetiic engineering and reporter molecules |
| 02/17/2005 | US20050037017 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/17/2005 | CA2678736A1 Novel multifunctional il-2 - il-18 fusion proteins |
| 02/17/2005 | CA2535517A1 Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 02/17/2005 | CA2535045A1 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 02/17/2005 | CA2534899A1 Polypeptides having brain-localizing activity and uses thereof |
| 02/17/2005 | CA2534520A1 Oligopeptide ligation methods comprising an activated ester moiety or an aldehyde or ketone moiety |
| 02/17/2005 | CA2534355A1 Compounds comprising lpa |
| 02/16/2005 | EP1507002A2 Thermostable Taq polymerase fragment |
| 02/16/2005 | EP1506318A2 Methods and compositions for regulation and manipulation of steroidogenesis |
| 02/16/2005 | EP1506317A2 Marker molecules associated with lung tumors |
| 02/16/2005 | EP1506306A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 02/16/2005 | EP1506291A2 Novel phospholipases and uses thereof |
| 02/16/2005 | EP1506215A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 02/16/2005 | CN1582336A Moraxella (branhamella) catarrhalis antigens |
| 02/16/2005 | CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/16/2005 | CN1582297A Hybrid and tandem expression of neisserial proteins |
| 02/16/2005 | CN1580265A T-20 fusion protein, and its preparing method and use |
| 02/16/2005 | CN1189557C Detecting and trapping receptor 3 monoclonal antibody, hybrid tumor for producing said antibody and its use |
| 02/15/2005 | US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof |
| 02/15/2005 | US6855693 Peptide for use in the treatment of cell damage caused by ischemia |
| 02/15/2005 | US6855321 Polyepitope carrier protein |
| 02/15/2005 | US6855317 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/10/2005 | WO2005012336A2 Uranium-chelating peptides and uses thereof |
| 02/10/2005 | WO2004104030A3 Peptides modulating the activity of the engrailed transcription factor |
| 02/10/2005 | WO2004003207A9 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 02/10/2005 | WO2003086175A8 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/10/2005 | WO2003060065A3 Adapter-directed display system |
| 02/10/2005 | US20050033035 Mutants of igf binding proteins and methods of production of antagonists thereof |
| 02/10/2005 | US20050033034 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032186 Regulatory zinc finger proteins |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032158 Using novel g-protein coupled taste receptor (T1R2) as tools in identifying modulators to use as additives which enhance sweetness of foods consumed by animal and humans |
| 02/10/2005 | US20050032059 Genetically modified hydrolase comprising enhanced activity for use in hydrolysis of starch to glucose; textile treatment; preparation of animal feeds |
| 02/10/2005 | US20050032047 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay |
| 02/10/2005 | CA2531231A1 Uranium-chelating peptides and uses thereof |
| 02/10/2005 | CA2530172A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/09/2005 | EP1504368A2 Method for crystallizing human gsk3 and novel crystal structure thereof |
| 02/09/2005 | EP1504036A2 Toxin-related antibodies with antimicrobial and antiviral activity |
| 02/09/2005 | EP1504027A2 Adipocyte complement related protein zacrp8 |
| 02/09/2005 | EP1503785A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |